Current treatment status-Currently treated Page 2 Posts on Medivizor
Navigation Menu

Current treatment status-Currently treated Posts on Medivizor

Can low disease activity be maintained in early rheumatoid arthritis without adalimumab?

Posted by on Sep 10, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if low disease activity could be maintained in early rheumatoid arthritis following discontinuation of long-term adalimumab. They found that the majority of patients that discontinued adalimumab maintained low disease activity after 3 years. Some background Rheumatoid arthritis is an autoimmune disease...

Read More

Anti-TNF therapy: Predictors of success

Posted by on Mar 15, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The study examined predictors of treatment success with anti-TNF drugs for rheumatoid arthritis (RA). The authors concluded that immune response and the presence of a protein in the blood can predict treatment outcomes with anti-TNF drugs. Some background In rheumatoid arthritis (RA), the immune system attacks the healthy joints the...

Read More

What is next for RA patients who have not responded to conventional treatment?

Posted by on Feb 8, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of two different treatments in rheumatoid arthritis (RA) patients who have not responded well to conventional treatment with disease-modifying anti-rheumatic drugs (DMARDs). The authors concluded that changing to a biological drug showed better remission rates than switching to an alternative...

Read More

Patient-reported side effects associated with methotrexate treatment for rheumatoid arthritis

Posted by on Nov 8, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at patient-reported side effects associated with methotrexate (Rheumatrex) when taken in tablet form or by injection for rheumatoid arthritis (RA). The authors concluded that there are a number of side effects associated with both forms of methotrexate that may not be recorded during routine treatment. Some background...

Read More

Comparing treatment options for rheumatoid arthritis unresponsive to anti-TNF drugs

Posted by on Oct 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of different biological drugs in patients with rheumatoid arthritis who have already been unresponsive to anti-tumor necrosis factor (TNF) treatment. The authors concluded that a non-TNF biological treatment was more effective at lowering disease activity than taking a second anti-TNF...

Read More

Are non-steroidal anti-inflammatory drugs associated with small intestinal injury?

Posted by on Sep 5, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the association between non-steroidal anti-inflammatory drugs (NSAIDs) and small intestinal injury in patients with rheumatoid arthritis and osteoarthritis. The authors concluded that there was a higher rate of small intestinal injury in patients treated with NSAIDs. Some background Patients with rheumatoid...

Read More

Does tocilizumab lead to intestinal perforation in patients with rheumatoid arthritis?

Posted by on Aug 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the risk of developing lower intestinal perforations (tears) in patients with rheumatoid arthritis treated with tocilizumab (Actemra). The authors concluded that tocilizumab treatment increases the risk of lower intestinal perforations compared to other treatments. Some background One problem encountered by some...

Read More

Do biological drug treatments for rheumatoid arthritis increase the risk of skin cancer?

Posted by on Jul 25, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell The study looked at the association between biological drug treatment for rheumatoid arthritis (RA) and the risk of melanoma (skin cancer). The authors concluded that there was no increased risk of melanoma in RA patients receiving treatment with biologics.   Some background In RA, the immune system attacks the healthy joints...

Read More